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Objectives: To assess medication knowledge in adult patients and to explore its determinants. 62 
Method: Cross-sectional study. Medication knowledge was the primary outcome, and was 63 
assessed using a previously validated questionnaire. A multivariate logistic regression analysis 64 
was performed to explore the association between medication knowledge and the factors 65 
included in the model. 66 
Results: 7,278 patients participated in the study. 71.9% (n=5,234) (95% CI: 70.9% - 73.0%) of 67 
the surveyed patients had an inadequate knowledge of the medication they were taking. The 68 
dimensions obtaining the highest level of knowledge were the "medication use process" and 69 
"therapeutic objective of medication". The items “frequency” (75.4%), “dosage” (74.5%) and 70 
“indication” (70.5%) had the highest percentage of knowledge. Conversely, "medication safety" 71 
represented the dimension with the lowest scores, ranging from 15.3% in the item “side effects” 72 
to 23% in the item “precautions and warnings”. The Odds Ratio of having an inadequate 73 
medication knowledge increased for unskilled workers (OR: 1.33; 85%CI:1.00-1.78; p=0.050), 74 
caregivers (OR:1.46; 95%CI:1.18-1.81; p<0.001), patients using more than one medication 75 
(OR: 1.14; 95%CI: 1.00-1.31; p=0.050), and patients who didn’t know the name of the 76 
medication they were taking (OR: 2.14, 95%CI: 1.71-2.68 p<0.001). 77 
Conclusion: Nearly three quarters of the analysed patients had inadequate knowledge 78 
regarding the medicines they were taking. Unskilled workers and caregivers were at a higher 79 
risk of lacking of medication knowledge. Other factors that correlated with inadequate 80 
medication knowledge were the use of more than one drug and not knowing the name of the 81 
medication dispensed.  82 
 83 
  84 
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1. INTRODUCTION 85 
Failures associated with pharmacotherapy have direct implications in terms of clinical, 86 
economic and humanistic outcomes. The prevalence of negative outcomes associated with the 87 
use of medicines is so high that it is considered to be a main public health problem 1-3. In Spain, 88 
the prevalence of visiting emergency departments due to negative outcomes related to 89 
medicines is 35.7%, of which between 73% and 81% are considered to be preventable 4, 5.  90 
While medicines are the most widely used technology to treat health problems, successful 91 
outcomes can only be achieved if they are used in an effective and safe manner. The World 92 
Health Organization concludes "No matter how effective and safe a product inherently is, it can 93 
only fulfill its function if it is properly used” 6. Of all those involved in the medication use 94 
process, the patient is the one that plays a central role in the attainment of medicines 95 
effectiveness and safety, wether this is either actively through conduct or due to his particular 96 
characteristics. Patients lacking correct information regarding medication use can be at higher 97 
risk of inappropriate use and suffering negative outcomes related to medicines. In fact, a direct 98 
correlation between medication knowledge, health service utilization and patient’s quality of 99 
life has been identified 7, 8. It has also been documented that patients with low medication 100 
knowledge are two times more likely to not adhere to their prescribed medications 9, 10 with 101 
negative clinical implications. Therefore, in order to minimise the occurrence of negative 102 
outcomes related to medicines and improve clinical and humanistic outcomes, patients should 103 
be properly informed and educated about their treatment and the self-management of their 104 
health condition 11. 105 
The concept “Patient Medication Knowledge” (PMK) is a term frequently used within 106 
healthcare professionals, but rarely defined in the literature 12, 13. Likewise no standardised 107 
assessment tool to adequately assess medication knowledge exists for most countries. 108 
Nevertheless, there is some evidence on the prevalence of PMK with some studies suggesting 109 
room for improvement 10, 11, 14-16. For example, the only two studies aiming at measuring PMK 110 
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using a previously validated tool stated that 82.46% of patients had insufficient knowledge 111 
about the medications they were using 17, 18. Similarly, although lack of PMK seems to be 112 
common in different groups of population, only few studies have explored specific factors 113 
associated with PMK. Health literacy, age, educational level or gender are some factors proven 114 
to be associated with PMK 19. Confirming and identifying further factors associated with PMK 115 
would allow the development of more focused strategies targeted to specific population groups, 116 
and consequently, a direct improvement in those outcomes associated with the use of 117 
medications.  118 
The objectives of the present study were to assess PMK in adult patients in Spain and to explore 119 
the determinants of PMK.  120 
2. METHODS 121 
2.1 Study design 122 
This cross-sectional study was conducted in community pharmacies located throughout the 123 
Spanish territory in February 2013.  124 
2.2 Patients 125 
The study population consisted of patients attending the participant pharmacies to get one or 126 
more medications dispensed (with or without prescription). Those patients having 127 
communication difficulties, those who had already participated in the study and those who had 128 
previously received some professional advice were excluded. Sample size was calculated to 129 
detect a prevalence of 66% of patients with insufficient knowledge about their medications 130 
(based on preliminary results obtained in the pilot study) with a maximum admissible error of ± 131 
4% at a 95% confidence level. Therefore a sample size of 8000 patients was required. A random 132 
sample of 10 patients meeting the inclusion criteria was systematically selected in each 133 
participant pharmacy.  134 
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2.3 Outcomes: 135 
All pharmacists were trained on interview techniques and the use of the research tools before 136 
the beginning of the study. PMK was the primary outcome, and was assessed using a previously 137 
validated questionnaire 20. When more than one drug was requested, one of them was randomly 138 
selected to measure PMK. The questionnaire consisted of 11 open questions that were asked by 139 
the pharmacist through a face-to-face interview. PMK was defined as the knowledge needed for 140 
appropriate use of the medication and was operationally defined and measured according to 4 141 
dimensions: therapeutic objective of the medication (including its indication and effectiveness), 142 
medication use process (dose, frequency, administration form and duration of treatment), safety 143 
issues related to the use of the medication (adverse effects, precautions and warnings, 144 
contraindications and interactions) and storage of the medication 20. Each question was assigned 145 
a score, ranging from -1 to 2 according to the degree of agreement between the patient’s 146 
response and the Spanish medicines handbook (medication reference book designed by the 147 
General Council of Spanish Pharmacists)21. The scoring system is shown in table 1. Based on 148 
the scored questionnaires, overall PMK was calculated. Overall PMK was categorised according 149 
to the following cutoff points of the validated questionnaire 20: no medication knowledge, 150 
insufficient medication knowledge, sufficient medication knowledge, and optimal medication 151 
knowledge. However, for statistical purposes Overall PMK was re-categorised into a 152 
dichotomous variable: inadequate medication knowledge (no medication knowledge and 153 
insufficient medication knowledge) and adequate medication knowledge (sufficient medication 154 
knowledge and optimal medication knowledge).  155 
Insert table 1 156 
2.4 Statistical analysis: 157 
Statistical analyses were performed using SPSS for Windows 15.0 (SPSS Inc, Chicago, Illinois, 158 
USA). Quantitative variables were expressed as the mean SD and categorical variables were 159 
expressed as frequency and percentages. To assess the strength and direction of the correlation 160 
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between PMK and each independent variable, a bivariate analysis (Chi-Squared Test, Student’s 161 
t-test and ANOVA) was performed. The prevalence ratio was used as a measure of association.  162 
A multivariate logistic regression analysis was performed to explore the association between 163 
PMK and all the factors included in the model. PMK was introduced as dependent variable 164 
(considering adequate PKM the reference category), and both those variables found to be 165 
significant in the bivariate analysis (using the backward procedure, no significant variables at a 166 
significance level of 0.05 were excluded), and those that were deemed necessary based on the 167 
theoretical model were introduced as independent variables.  168 
2.5 Ethical approval 169 
Approval for the study was given by the Ethics and Research Committee of the Clinic Hospital 170 
in Barcelona (Approval number: PFI-NUL-2012-01). A written information sheet was provided 171 
and informed consent was obtained. 172 
3. RESULTS 173 
Overall, 800 community pharmacies from 49 Spanish provinces participated in the study. 8000 174 
patients were selected, of which 9.03% were excluded, resulting in a response rate of 90.97%. 175 
More than a half of the included patients were female (58.4%), with a mean age of 54 years 176 
(SD: 17.2). Most of them were Spanish (95.3%), and non-workers (51.1%). 43.8% of them 177 
expressed strong concern about their health problems. 88.9% of included patients acquired the 178 
drug for their own use and 85.9% of them knew the name of the drug they were acquiring. Most 179 
patients (87.9%) had used the drug before. In 90.7% of cases the drug was prescribed by a 180 
physician (Table 2).   181 
Insert Table 2 182 
3.1 Prevalence of PMK  183 
3.1.1 Overall PMK 184 
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71.9% (n=5,234) (95% CI: 70.9% - 73.0%) of the surveyed patients had an inadequate 185 
knowledge of the medication they were taking; among them the 65.7% (n=4,782) had no 186 
medication knowledge and the remaining 6.2% (n=452) presented insufficient medication 187 
knowledge (Figure 1). Only 28% of the surveyed patients had an adequate knowledge of the 188 
medication taken, with 14.0%  (n=1026) presenting sufficient medication knowledge and 14.0% 189 
(n=1018) optimal medication knowledge (Figure 1).  190 
Insert Figure 1 191 
3.1.2 PMK by dimensions and items 192 
Those PMK dimensions obtaining the highest level of knowledge were the "medication use 193 
process" and "therapeutic objective of medication". The items “frequency” (75.4%), “dosage” 194 
(74.5%) and “indication” (70.5%) had the highest percentage of knowledge. Conversely, 195 
"medication safety" represented the dimension with the lowest scores, ranging from 15.3% in 196 
the item “side effects” to 23% in the item “precautions and warnings” (Table 3). 197 
Insert table 3 198 
3.2 Factors associated with PMK 199 
3.2.1 Bivariate analysis 200 
No statistically significant differences were observed between the prevalence of overall PMK 201 
and gender (p=0.649), country of birth (p=0.805) and medication prescriber (p= 0.208).  202 
Significant differences were observed for the variables age, level of education, professional 203 
status, concern about health problems, knowledge of the medication name, number of 204 
medications used, duration of medication use and medication user. 205 
3.2.2 Multivariate analysis 206 
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After selecting the optimal model using the backward procedure, 7 factors clearly associated 207 
with PMK were identified: educational level, professional status, medication user, concern 208 
about health problem, number of medications used, duration of medication use and knowledge 209 
of the medication name (Table 4). Based on this model, the Odds Ratio of having an inadequate 210 
medication knowledge increased for unskilled workers (OR:1.33; 85%CI:0.99-1.78; p=0.050), 211 
caregivers (OR:1.46; 95%CI:1.18-1.81; p<0.001), patients using more than one medication 212 
(OR: 1.14; 95%CI: 1.00-1.31; p=0.050), and patients who didn’t know the name of the 213 
medication they were taking (OR: 2.14, 95%CI: 1.71-2.68 p<0.001). However higher levels of 214 
education, being concerned about the health problem, and previous use of the medication were 215 
found to be factors associated with adequate knowledge of the medication.  216 
Insert table 4 217 
4. DISCUSSION 218 
The results from the present study show a lack of overall PMK among the Spanish population. 219 
In fact, 72% of the analysed patients had inadequate knowledge of the medication they were 220 
taking. The study expands upon previous work, analysing the factors associated with PMK.   221 
Our findings are in consonance with previous studies where a high prevalence of inadequate 222 
PMK has already been identified in different groups of the population. Some authors have 223 
estimated that the prevalence of inadequate PMK ranges between 42.5% and 57% 22-26. A recent 224 
study conducted in emergency department units concluded that 83% of patients had no 225 
knowledge about the medications given on discharge 27. In Spain, previous research has shown 226 
similar results, with 66% (95% CI: 63.3%-68.7%) and 83% of patients lacking PMK 18 28. Once 227 
more, these rates are very similar to the ones found in a latter study undertaken in Portugal, 228 
where the prevalence of inadequate PMK was found to be 82.5% (95% CI: 79.3% -85.3%)17.  229 
By observing the individual components of PMK assessed, our findings revealed that important 230 
factors within the medication-use process, such as “duration of treatment” or “form of 231 
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administration”, were only known by 58.9% and 58.1% of our population respectively. These 232 
percentages are very similar to the ones previously reported in a study aiming at assessing PMK 233 
in outpatients from a medicine clinic 29, suggesting there is a high percentage of patients who 234 
lack the required information to ensure the proper use of their medication. There is evidence 235 
that wrong administration leads to medication misuse and increases the risk of suffering from 236 
negative outcomes related to medications. It is worth mentioning the negative implications this 237 
has for different conditions such as COPD or asthma, in which improper use of medications has 238 
been found to be associated with poor clinical outcomes and increased use of health care 239 
resources 30-32. Surprisingly, the dimensions “medication safety issues” and “storage of 240 
medications” obtained the lowest scores, ranging from 12.6% in the item “contraindications” to 241 
36.7% for the item “storage”.  242 
This fact highlights a big gap in the patient information process, causing potential negative 243 
safety consequences. Health care implications of these findings include a need for implementing 244 
effective and ongoing medication education strategies. Patients should be educated not only on 245 
indications and doses (which are the elements of the medication use process best known), but 246 
also on expected and possible adverse effects, interactions, and strategies to reduce potential 247 
errors. Furthermore, a latter systematic review of systematic reviews, which aimed at 248 
synthesising the evidence on the effects of interventions to influence medication use, found that 249 
while some strategies (such as providing information or education as single interventions) may 250 
be ineffective, complex interventions seem to be the most effective. Strategies that appeared to 251 
improve medicines use included: medicines self-monitoring and self-management, simplified 252 
dosing and direct involvement of pharmacists in medication management. Further interventions 253 
including reminders, education combined with self management skills training, and counselling 254 
or support; were promising but less consistent 33. As evidenced, PMK is an important factor 255 
determining patient´s adherence and is directly linked to health care resources use and quality of 256 
life 34 8. Taking into account the global increase in the use of medicines, the need to design 257 
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improved medication education programs in order to contribute to the sustainability and 258 
optimisation of the health care system is most relevant. 259 
Our study results indicate that patients with no education, unskilled workers, or caregivers were 260 
at a higher risk of inadequate PMK. A number of other studies have also identified associations 261 
between some of these factors and a lack of PMK 10, 19, 35. Although the mentioned socio 262 
demographic characteristics are non-modifiable, and therefore cannot be altered or addressed 263 
with feasible interventions, they may be used to identify patients with a lack of medication 264 
knowledge. This would allow the provision of selective interventions in different settings, 265 
targeted to specific groups of the population in order to improve PMK. The same rationale 266 
could be applied to other factors found to be associated with inadequate PMK, such as patients 267 
taking more than one medication, expressing low concern about their health care problem or 268 
taking the medication for the first time. Physicians, pharmacists and nurses could use these 269 
indicators as a tool for screening or detecting medication knowledge problems and address them 270 
during their early interaction with the patient. It's worthwhile pointing out that although age has 271 
been reported to be one of the most correlated factors associated with a lack of PMK in the 272 
literature 7, 18, 36-38, no correlation was found in our analysis. While similar results were obtained 273 
in our crude analysis, no association was identified in the multivariate model. 274 
One of the strengths of this study is the use of a valid and reliable tool to measure PKM 20. This 275 
is an outcome that has been usually assessed with ad-hoc and non-validated tools, evaluating 276 
individual epistemological components rather than PMK as a whole, therefore limiting the 277 
validity of the results found. Additionally, the questionnaire used was designed to weight the 278 
different indicators comprising PMK (i.e. The importance of not knowing the adverse effects of 279 
the medication taken is not the same as not knowing how to administer the medication), 280 
showing its effect on the final score obtained. Furthermore the high response rate and the large 281 
sample of patients analysed and the sampling method used guarantees the representability of the 282 
population attending community pharmacies in Spain. However some limitations must be 283 
mentioned. Firstly only community pharmacy users were included in the study and therefore 284 
12 
 
extrapolation of our results to other settings may be limited. Secondly for those patients 285 
requesting two or more medications, PMK was only assessed for one of the medications 286 
requested. To minimise selection bias, the study medication was randomly selected.  287 
In conclusion, a high prevalence of inadequate patient medication knowledge among the 288 
Spanish population has been identified. Nearly three quarters of the analysed patients had no 289 
knowledge or insufficient knowledge regarding the medicines they were taking. Patients with 290 
no education, unskilled workers, and caregivers were at a higher risk of lacking of PMK. Other 291 
factors that correlated with inadequate PMK were a lack of concern about the health problem, 292 
the use of more than one drug, being a first time user of and not knowing the name of the 293 
medication. Future research should address the development and implementation of effective 294 
educational strategies in primary health care settings.  295 
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7. TABLES: 441 
Tables 442 
 443 
Table 1. Scoring system for the Patient Medication Knowledge Questionnaire 
Classification Score Explanation 
Incorrect answer -1 The information provided by the patient does 
not match with the medication reference 
book. 
‘Don’t know’ answer 0 The patient declares through verbal or non-
verbal communication that he/she doesn’t 
know the answer for the question asked. 
Incomplete answer 1 The patient’s response is incomplete and 
does not ensure the correct and safe use of 
the medication in relation to the question 
asked. 
Correct answer 2 The information provided by the patient 
matches with the medication reference book.  





  447 
Table 2. Sociodemographic characteristics of study patients  (n=7,278) 
Variable  
Gender (Female); n(%) 4,153 (58.4) 
Age (Years); mean (SD) 54 (17.2) 
Professional status 
Non-workers; n(%) 3,654 (51.1) 
Unskilled worker with no qualifications; n(%)   467 (6.5) 
Skilled labourer  with qualifications; n(%) 682 (9.5) 
Administrative workers; n(%) 1,246 (17.4) 
University qualified; n(%) 785 (11) 
Managers and business persons; n(%) 318 (4.4) 
Country of birth  
Spain; n(%) 6,877 (95.3) 
European country other than Spain; n(%) 119 (1.6) 
European country not a member of the EU; n(%) 45 (0.6) 
North American country; n(%) 34 (0.5) 
Central or South American country; n(%) 74 (1.0) 
Other; n(%) 67 (0.9) 
Level of education  
No education; n(%) 1,035 (14.3) 
Primary ; n(%) 2,266 (31.3) 
Secondary/Vocational education; n(%) 2,128 (29.4) 
University ; n(%) 1,816 (25.1) 
Concern about the health problem 
Low; n(%) 1,386 (19.1) 
Fair; n(%) 2,366 (32.6) 
High; n(%) 3,512 (48.3) 
Aquisition of medicine for own use; n(%)  6,368 (88.9) 
Use of more than one medication; n(%)  4,576 (62.9) 
Knows the name of the medication; n(%) 6,250 (85.9) 
First time user 877 (12.1) 
Source of medication recommendation 
Prescribed by a physician; n(%) 6,600 (90.7) 
Recommended by a pharmacist; n(%) 428 (5.9) 
Self medication; n(%) 221 (3.0) 
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Indication 168 (2.3%) 293 (4.0%) 1685 (23.2%) 5132 (70.5%) 
Effectiveness 312 (4.3%) 1430 (19.6%) 2317 (31.8%) 3219 (44.2%) 
Medication 
use process 
Dosage 211 (2.9%) 423 (5.8%) 1221 (16.8%) 5423 (74.5%) 
Frequency 162 (2.2%) 395 (5.4%) 1230 (16.9%) 5491 (75.4%) 
Duration of 
treatment 
250 (3.4%) 1143 (15.7%) 1597 (21.9%) 4288 (58.9%) 
Form of 
administration 





1163 (16.0%) 2703 (37.1%) 1736 (23.9%) 1676 (23.0%) 
Side Effects 1065 (14.6%) 3385 (46.5%) 1718 (23.6%) 1110 (15.3%) 
Contraindication 991 (13.6%) 4211 (57.9%) 1158 (15.9%) 918 (12.6%) 
Interaction 837 (11.5%) 3344 (45.9%) 1657 (22.8%) 1440 (19.8%) 
Storage of 
medication 
Storage 707 (9.7%) 1426 (19.6%) 2472 (34.0%) 2673 (36.7%) 
 448 
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IC 95% p 
Level of education 
No education 1 - - 
Primary  0.58 (0.47-0.73) <0.001 
Secondary/Vocational education 0.55 (0.43-0.70) <0.001 
University  0.52 (0.40-0.69) <0.001 
Professional status 
Non-workers 1 - - 
Unskilled worker with no qualifications  1.33 (0.99-1.78) 0.050 
Skilled labourer with qualifications 0.83 (0.67-1.03) 0.091 
Administrative workers 0.80 (0.66-0.97) 0.020 
University qualified 0.73 (0.56-0.94) 0.014 
Managers and business persons 0.74 (0.54-1.01) 0.050 
Person acquiring the medication  
Own user 1 - - 
Caregiver 1.46 (1.18-1.81) 0.001  
Concern about the health problem  
Low 1 - - 
Fair 0.91 (0.76-1.08) 0.282 
High 0.80 (0.67-0.94) 0.009 
Number of medications used  
One medication 1 - - 
More than one medication 1.14 (1.00-1.31) 0.050 
Duration of medication use  
First time user 1 - - 
Not a first time user 0.74 (0.61-0.91) 0.004 
Knowledge of the medication name 
  Yes 1 - - 
  No 2.14 (1.71-2.68) <0.001 
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8. FIGURES 452 
 453 
 454 
Figure 1. Prevalence of overall Patient Medication Knowledge (N= 7,278) 455 
 456 
 457 
 458 
 459 
 460 
